Organigram Global Inc.(OGI)Earnings, Financials & Key Ratios
OGI•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutOrganigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.Show more
- Revenue$186M+16.4%
- EBITDA-$50M-114.1%
- Net Income-$18M+60.9%
- EPS (Diluted)-0.14+70.8%
- Gross Margin3.67%-87.7%
- EBITDA Margin-27.14%-83.9%
- Operating Margin-34.07%-52.7%
- Net Margin-9.55%+66.4%
- ROE-5.43%+65.5%
OGI Key Insights
Organigram Global Inc. (OGI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 33.4%
- ✓Strong 5Y sales CAGR of 16.5%
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 10 (bottom 10%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 34.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when OGI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OGI Price & Volume
Organigram Global Inc. (OGI) stock price & volume — 10-year historical chart
Loading chart...
OGI Growth Metrics
Organigram Global Inc. (OGI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years68.87%
5 Years16.48%
3 Years8.47%
TTM32.58%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-247.88%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-291.87%
Return on Capital
10 Years-14.54%
5 Years-23.29%
3 Years-29.4%
Last Year-16.04%
OGI Recent Earnings
Organigram Global Inc. (OGI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 2/12 qtrs (17%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.01+0.0%
$0.01
Rev
$43M-15.0%
$51M
Q1 2026
Feb 10, 2026Metric
Actual
Est
EPS
$0.02-100.0%
$0.01
Rev
$46M-13.1%
$53M
Q4 2025
Dec 16, 2025Metric
Actual
Est
EPS
$0.20-4058.0%
$0.00
Rev
$57M+13.6%
$51M
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.03-200.0%
$0.01
Rev
$52M-28.8%
$73M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.01vs $0.01+0.0% | $43Mvs $51M-15.0% |
| Q1 2026 | Feb 10, 2026 | $0.02vs $0.01-100.0% | $46Mvs $53M-13.1% |
| Q4 2025 | Dec 16, 2025 | $0.20vs $0.00-4058.0% | $57Mvs $51M+13.6% |
| Q3 2025 | Aug 13, 2025 | $0.03vs $0.01-200.0% | $52Mvs $73M-28.8% |
Based on last 12 quarters of dataView full earnings history →
OGI Peer Comparison
Organigram Global Inc. (OGI) competitors in Cannabis and cannabinoid product companies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CGC | 372.36M | 0.97 | -1.55 | 79.81% | -117.39% | -49.5% | 0.33 | |
 TLRY | 551.15M | 4.73 | -0.14 | 4.84% | -252.55% | -136.55% | 0.22 | |
 ACB | 181.49M | 2.93 | -1.92 | -6.37% | -24.14% | -13.4% | 0.05 | |
 CRON | 1.01B | 2.71 | -110.61 | 64.4% | -0.98% | -0.18% | 0.00 | |
 SNDL | 368.06M | 1.42 | -33.38 | 2.82% | -1.17% | -1% | 0.15 | |
 SMG | 3.75B | 64.69 | 26.19 | -3.93% | 2.68% | |||
 IIPR | 1.7B | 59.60 | 15.17 | -13.8% | 45.58% | 6.41% | 0.21 | |
 LWAY | 388.62M | 25.43 | 28.57 | 13.74% | 6.54% | 17.76% | 0.01 |
Compare OGI vs Peers
Organigram Global Inc. (OGI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OGI Income Statement
Organigram Global Inc. (OGI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 5.39M | 12.43M | 80.41M | 86.8M | 79.16M | 145.81M | 149.21M | 159.84M | 186.09M | 257.33M |
Revenue Growth % | -12.06% | 130.64% | 546.98% | 7.94% | -8.79% | 84.19% | 2.33% | 7.13% | 16.42% | 32.58% |
Cost of Goods Sold | 8.69M | -39.2M | 31.94M | 143.28M | 107.56M | 114.24M | 114.13M | 112.32M | 179.26M | 182.55M |
COGS % of Revenue | 161.18% | -315.42% | 39.72% | 165.08% | 135.87% | 78.35% | 76.49% | 70.27% | 96.33% | - |
Gross Profit | -3.3M▲ 0% | -26.77M▼ 712.1% | 48.47M▲ 281.0% | -56.49M▼ 216.5% | -28.4M▲ 49.7% | 31.57M▲ 211.2% | 35.07M▲ 11.1% | 47.52M▲ 35.5% | 6.83M▼ 85.6% | 74.82M▲ 0% |
Gross Margin % | -61.18% | -215.42% | 60.28% | -65.08% | -35.87% | 21.65% | 23.51% | 29.73% | 3.67% | 29.08% |
Gross Profit Growth % | -162.04% | -712.1% | 281.02% | -216.55% | 49.73% | 211.16% | 11.1% | 35.5% | -85.63% | - |
Operating Expenses | 7.8M | 15.22M | 42.37M | 89.02M | 63.42M | 74.72M | 271.48M | 83.19M | 70.24M | 102.91M |
OpEx % of Revenue | 144.81% | 122.43% | 52.69% | 102.56% | 80.11% | 51.25% | 181.95% | 52.05% | 37.74% | - |
Selling, General & Admin | 7.39M | 15.22M | 41.3M | 46.47M | 46.47M | 59.21M | 71.68M | 68.14M | 86.88M | 86.79M |
SG&A % of Revenue | 137.21% | 122.43% | 51.35% | 53.54% | 58.7% | 40.61% | 48.04% | 42.63% | 46.68% | - |
Research & Development | 0 | 0 | 409K | 1.27M | 3.45M | 5.96M | 12.19M | 11.2M | 10.95M | 9.45M |
R&D % of Revenue | - | - | 0.51% | 1.46% | 4.36% | 4.09% | 8.17% | 7.01% | 5.88% | - |
Other Operating Expenses | 410K | 0 | 664K | -6.37M | -5.53M | 5.14M | 193.95M | 3.85M | -27.59M | 3M |
Operating Income | -11.1M▲ 0% | 36.42M▲ 428.0% | 5.49M▼ 84.9% | -145.51M▼ 2751.9% | -91.82M▲ 36.9% | -43.15M▲ 53.0% | -242.74M▼ 462.5% | -35.67M▲ 85.3% | -63.41M▼ 77.7% | -28.09M▲ 0% |
Operating Margin % | -205.99% | 292.99% | 6.82% | -167.65% | -115.99% | -29.59% | -162.69% | -22.32% | -34.07% | -10.91% |
Operating Income Growth % | -990.93% | 428.04% | -84.93% | -2751.9% | 36.9% | 53% | -462.53% | 85.3% | -77.75% | - |
EBITDA | -9.54M | 39.94M | 14.39M | -127.55M | -60.79M | -18.24M | -219.31M | -23.59M | -50.5M | -9.74M |
EBITDA Margin % | -177.12% | 321.38% | 17.89% | -146.96% | -76.79% | -12.51% | -146.99% | -14.76% | -27.14% | -3.79% |
EBITDA Growth % | -569.83% | 518.48% | -63.98% | -986.45% | 52.34% | 69.99% | -1102.12% | 89.24% | -114.05% | -102.53% |
D&A (Non-Cash Add-back) | 1.56M | 3.53M | 8.9M | 17.96M | 31.03M | 24.91M | 23.43M | 12.08M | 12.91M | 18.34M |
EBIT | -10.55M | 37.87M | 3.79M | -140.62M | -127.74M | -13.94M | -48.79M | -35.67M | -27.66M | -28.09M |
Net Interest Income | -264K | -10.09M | -9.67M | -6.01M | -2.96M | -429K | 3.41M | 0 | 825.7K | 370.84K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 3.69M | 0 | 825.7K | 370.84K |
Interest Expense | 264K | 10.09M | 9.67M | 6.01M | 2.96M | 429K | 277.85K | 0 | 0 | 0 |
Other Income/Expense | 288K | -8.64M | -11.36M | -1.12M | -38.88M | 28.78M | -184.21M | -9.77M | 35.74M | -10.53M |
Pretax Income | -10.81M▲ 0% | 27.78M▲ 356.9% | -5.88M▼ 121.2% | -146.63M▼ 2395.8% | -130.7M▲ 10.9% | -14.37M▲ 89.0% | -233M▼ 1521.3% | -45.44M▲ 80.5% | -27.66M▲ 39.1% | -38.63M▲ 0% |
Pretax Margin % | -200.65% | 223.49% | -7.31% | -168.94% | -165.11% | -9.86% | -156.16% | -28.43% | -14.87% | -15.01% |
Income Tax | 0 | 5.65M | 3.63M | -10.47M | 0 | -88K | -3.52M | 0 | -9.89M | -13.66M |
Effective Tax Rate % | 0% | 20.35% | -61.77% | 7.14% | 0% | 0.61% | 1.51% | 0% | 35.74% | 35.37% |
Net Income | -10.89M▲ 0% | 20.51M▲ 288.4% | -9.54M▼ 146.5% | -136.16M▼ 1326.9% | -130.7M▲ 4.0% | -14.28M▲ 89.1% | -229.48M▼ 1506.7% | -45.44M▲ 80.2% | -17.78M▲ 60.9% | -24.97M▲ 0% |
Net Margin % | -202.08% | 165.04% | -11.87% | -156.87% | -165.11% | -9.8% | -153.8% | -28.43% | -9.55% | -9.7% |
Net Income Growth % | -1386.23% | 288.37% | -146.52% | -1326.92% | 4% | 89.07% | -1506.65% | 80.2% | 60.88% | -247.88% |
Net Income (Continuing) | -10.81M | 22.12M | -9.5M | -136.16M | -130.7M | -14.28M | -229.48M | -45.44M | -17.78M | -24.97M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.45▲ 0% | 0.65▲ 244.4% | -0.27▼ 141.5% | -3.15▼ 1066.7% | -2.04▲ 35.2% | -0.18▲ 91.2% | -2.82▼ 1466.7% | -0.48▲ 83.0% | -0.14▲ 70.8% | -0.19▲ 0% |
EPS Growth % | -879.9% | 244.44% | -141.54% | -1066.67% | 35.24% | 91.18% | -1466.67% | 82.98% | 70.83% | -291.87% |
EPS (Basic) | -0.45 | 0.68 | -0.27 | -3.15 | -2.04 | -0.18 | -2.82 | -0.48 | -0.14 | - |
Diluted Shares Outstanding | 24.3M | 31.71M | 35.23M | 43.17M | 64.03M | 85.3M | 81.29M | 95.29M | 127.67M | 131.57M |
Basic Shares Outstanding | 24.3M | 30.14M | 35.23M | 43.17M | 64.03M | 80.01M | 81.29M | 95.29M | 127.67M | 131.57M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
OGI Balance Sheet
Organigram Global Inc. (OGI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 44.67M | 203.21M | 196.28M | 170.2M | 260.62M | 221.62M | 155.98M | 262.22M | 284.9M | 250.73M |
Cash & Short-Term Investments | 33.96M | 130.06M | 47.94M | 74.73M | 183.84M | 98.91M | 33.86M | 107.57M | 29.03M | 54.9M |
Cash Only | 1.96M | 55.06M | 47.55M | 24.6M | 55.37M | 68.52M | 33.86M | 106.75M | 28.2M | 54.08M |
Short-Term Investments | 32M | 75M | 380K | 50.13M | 128.48M | 30.4M | 0 | 821K | 826K | 813.1K |
Accounts Receivable | 1.01M | 793K | 11.63M | 16.98M | 21M | 46.37M | 27.46M | 37.15M | 64.86M | 53.53M |
Days Sales Outstanding | 68.2 | 23.29 | 52.8 | 71.39 | 96.81 | 116.08 | 67.17 | 84.84 | 127.21 | 80.08 |
Inventory | 5.41M | 64.83M | 113.8M | 71.76M | 48.82M | 68.28M | 80.95M | 82.52M | 123.95M | 135.51M |
Days Inventory Outstanding | 227.16 | -603.56 | 1.3K | 182.8 | 165.66 | 218.16 | 258.89 | 268.18 | 252.38 | 258.55 |
Other Current Assets | 3.58M | 1.22M | 5.82M | 0 | 0 | 2.21M | 13.7M | 25.86M | 55.39M | 6.8M |
Total Non-Current Assets | 48.14M | 99.35M | 232.24M | 247.42M | 293.4M | 355.48M | 142.48M | 145.64M | 277.31M | 271.93M |
Property, Plant & Equipment | 45.35M | 98.64M | 219.05M | 247.42M | 235.94M | 259.82M | 99.05M | 96.23M | 122.98M | 121.15M |
Fixed Asset Turnover | 0.12x | 0.13x | 0.37x | 0.35x | 0.34x | 0.56x | 1.51x | 1.66x | 1.51x | 2.10x |
Goodwill | 2.33M | 0 | 0 | 0 | 14.32M | 41.98M | 0 | 0 | 52.52M | 52.66M |
Intangible Assets | 0 | 0 | 1.5M | 1.77M | 2.73M | 14.26M | 10.62M | 8.09M | 48.51M | 39.32M |
Long-Term Investments | 0 | 0 | 11.11M | 7M | 6.11M | 7.07M | 13.72M | 40.73M | 49.55M | 166.1M |
Other Non-Current Assets | 467.49K | 714K | 592K | 8.03M | 31.11M | 32.36M | 19.09M | 591K | 3.75M | 1.52M |
Total Assets | 92.81M▲ 0% | 302.57M▲ 226.0% | 428.52M▲ 41.6% | 417.62M▼ 2.5% | 554.02M▲ 32.7% | 577.11M▲ 4.2% | 298.45M▼ 48.3% | 407.86M▲ 36.7% | 562.21M▲ 37.8% | 522.66M▲ 0% |
Asset Turnover | 0.06x | 0.04x | 0.19x | 0.21x | 0.14x | 0.25x | 0.50x | 0.39x | 0.33x | 0.47x |
Asset Growth % | 72.29% | 226.01% | 41.63% | -2.54% | 32.66% | 4.17% | -48.28% | 36.66% | 37.84% | 104.82% |
Total Current Liabilities | 6.65M | 11.25M | 43.86M | 29.08M | 26.27M | 55.28M | 22.43M | 53.32M | 126.16M | 88.97M |
Accounts Payable | 6.26M | 10.76M | 40.35M | 17.49M | 18.95M | 40.86M | 14.73M | 47.1M | 89.25M | 73.33M |
Days Payables Outstanding | 263.01 | -100.22 | 461.11 | 44.54 | 64.31 | 130.56 | 47.1 | 153.05 | 181.72 | 161.65 |
Short-Term Debt | 389.82K | 421K | 3.51M | 11.6M | 80K | 80K | 76K | 60K | 25K | 959.47K |
Deferred Revenue (Current) | 0 | 0 | -3.51M | 0 | 0 | 2.44M | 0 | 0 | 0 | 0 |
Other Current Liabilities | -659 | 65K | 0 | 0 | 6.25M | 12M | 2.35M | 5.14M | 35.91M | 14.69M |
Current Ratio | 6.72x | 18.06x | 4.47x | 5.85x | 9.92x | 4.01x | 6.95x | 4.92x | 2.26x | 2.82x |
Quick Ratio | 5.91x | 12.30x | 1.88x | 3.39x | 8.06x | 2.77x | 3.34x | 3.37x | 1.28x | 1.30x |
Cash Conversion Cycle | 32.35 | -480.05 | 891.95 | 209.64 | 198.16 | 203.68 | 278.96 | 199.97 | 197.88 | 176.98 |
Total Non-Current Liabilities | 3.13M | 106.72M | 57.66M | 89.02M | 47.95M | 13.76M | 4.4M | 48.55M | 86.92M | 60.91M |
Long-Term Debt | 3.13M | 98.74M | 46.07M | 103.67M | 230K | 155K | 3.63M | 25K | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 2.62M | 4.65M | 2.21M | 0 | 3.34M | 7.75M | 30.5M |
Deferred Tax Liabilities | 0 | 7.98M | 10.47M | 0 | 0 | 3.62M | 0 | 0 | 0 | 3.74M |
Other Non-Current Liabilities | 510 | 0 | 1.12M | -17.27M | 43.06M | 7.79M | 771K | 45.18M | 79.17M | 53.65M |
Total Liabilities | 9.78M | 117.97M | 101.52M | 118.1M | 74.21M | 69.05M | 26.83M | 101.87M | 213.08M | 149.89M |
Total Debt | 3.52M | 99.16M | 49.58M | 103.67M | 5.95M | 3.36M | 3.71M | 4.46M | 8.75M | 8.22M |
Net Debt | 1.56M | 44.1M | 2.02M | 79.07M | -49.42M | -65.16M | -30.16M | -102.29M | -19.45M | -45.86M |
Debt / Equity | 0.04x | 0.54x | 0.15x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.02x |
Debt / EBITDA | - | 2.48x | 3.45x | - | - | - | - | - | - | -0.84x |
Net Debt / EBITDA | - | 1.10x | 0.14x | - | - | - | - | - | - | 4.71x |
Interest Coverage | -39.96x | 3.75x | 0.39x | -23.41x | -43.16x | -32.50x | -175.60x | - | - | - |
Total Equity | 83.03M▲ 0% | 184.59M▲ 122.3% | 327.01M▲ 77.1% | 299.53M▼ 8.4% | 479.81M▲ 60.2% | 508.06M▲ 5.9% | 271.62M▼ 46.5% | 305.99M▲ 12.7% | 349.13M▲ 14.1% | 372.77M▲ 0% |
Equity Growth % | 87.6% | 122.32% | 77.15% | -8.4% | 60.19% | 5.89% | -46.54% | 12.65% | 14.1% | 53.9% |
Book Value per Share | 3.42 | 5.82 | 9.28 | 6.94 | 7.49 | 5.96 | 3.34 | 3.21 | 2.73 | 2.83 |
Total Shareholders' Equity | 83.03M | 184.59M | 327.01M | 299.53M | 479.81M | 508.06M | 271.62M | 305.99M | 349.13M | 372.77M |
Common Stock | 99.7M | 157.79M | 318.13M | 420.67M | 730.8M | 769.73M | 776.91M | 852.89M | 919.91M | 926.57M |
Retained Earnings | -19.75M | 759K | -8.78M | -144.94M | -275.64M | -289.93M | -538.53M | -583.97M | -608.73M | -591.2M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 3.08M | 26.05M | 17.66M | 23.79M | 24.65M | 28.26M | 33.24M | 37.07M | 37.95M | 37.4M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OGI Cash Flow Statement
Organigram Global Inc. (OGI) cash flow — operating, investing & free cash flow history
| Metric | Aug'17 | Aug'18 | Aug'19 | Aug'20 | Aug'21 | Aug'22 | Sep'23 | Sep'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -6.11M | -12.7M | -35.08M | -45.13M | -28.59M | -36.21M | -35.8M | 3.87M | -4.3M | -8.39M |
Operating CF Margin % | -113.4% | -102.21% | -43.63% | -51.99% | -36.11% | -24.83% | -23.99% | 2.42% | -2.31% | - |
Operating CF Growth % | -244.85% | -107.88% | -176.14% | -28.63% | 36.64% | -26.66% | 1.15% | 110.82% | -211.07% | 166.44% |
Net Income | -10.89M | 22.12M | -9.5M | -136.16M | -130.7M | -14.28M | -229.48M | -45.44M | -24.76M | -24.97M |
Depreciation & Amortization | 1.55M | 3.53M | 8.9M | 17.96M | 31.03M | 24.91M | 24.08M | 12.08M | 17.98M | 19.77M |
Stock-Based Compensation | 2.21M | 5.03M | 14.89M | 7.8M | 3.9M | 5.13M | 5.29M | 7.18M | 4.22M | 1.95M |
Deferred Taxes | -102.81K | -1.86M | 3.63M | -10.47M | 42.21M | -88K | 0 | 0 | -13.77M | -13.66M |
Other Non-Cash Items | 625.14K | -643K | 4.01M | 46.71M | 776K | -29M | 151.8M | 15.09M | 14.16M | 14.83M |
Working Capital Changes | 494.43K | -40.88M | -57.02M | 29.04M | 24.2M | -22.88M | 12.51M | 14.96M | -2.12M | -6.06M |
Change in Receivables | -2.42M | 337K | -13.13M | 1.79M | -6.01M | -24.02M | 12.51M | -12.06M | -15.29M | -17.4M |
Change in Inventory | 550.6K | -48.68M | -40.91M | 45.64M | 28.68M | -12.22M | 0 | 0 | 0 | 0 |
Change in Payables | 3.89M | 3.98M | 10.56M | -28M | 2.06M | 12.15M | 0 | 0 | 0 | 0 |
Cash from Investing | -42.6M | -98M | -46.78M | -138.2M | -115.11M | 44.03M | 4.56M | -38.77M | -59.35M | -15.83M |
Capital Expenditures | -34.33M | -56.44M | -110.29M | -78.65M | -12.33M | -48.78M | -26.9M | -4.73M | -17.02M | -11.24M |
CapEx % of Revenue | 637.04% | 454.06% | 137.16% | 90.62% | 15.57% | 33.45% | 18.03% | 2.96% | 9.15% | 4.37% |
Acquisitions | 114.7K | 15K | -12.76M | -1.43M | -2.54M | -11.06M | 0 | 0 | -65.62M | -747K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 294.16K | -17K | 621K | -8.64M | -31.07M | 4.29M | 31.46M | -8.32M | 21.8M | -5.37M |
Cash from Financing | 40.81M | 163.91M | 74.33M | 160.37M | 174.46M | 5.33M | -754.15K | 107.78M | 28.24M | -1.87M |
Debt Issued (Net) | -1.78M | 114.77M | 46.18M | 63.34M | -116.4M | -1.01M | 0 | -786K | -43.08K | -599.78K |
Equity Issued (Net) | 40.25M | 57.5M | 0 | 100M | 284.88M | 0 | 0 | 108.56M | 29.57M | -42.2K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 2.33M | -8.36M | 28.15M | -2.97M | 5.99M | 6.34M | -754.15K | 6K | -1.29M | -1.23M |
Net Change in Cash | -7.9M▲ 0% | 53.11M▲ 772.2% | -7.51M▼ 114.1% | -22.95M▼ 205.7% | 30.77M▲ 234.0% | 13.15M▼ 57.3% | -68.52M▼ 621.0% | 72.88M▲ 206.4% | -37.98M▼ 152.1% | -29.19M▲ 0% |
Free Cash Flow | -40.44M▲ 0% | -69.14M▼ 71.0% | -145.38M▼ 110.3% | -123.78M▲ 14.9% | -40.92M▲ 66.9% | -84.99M▼ 107.7% | -62.7M▲ 26.2% | -1.47M▲ 97.7% | -16.52M▼ 1027.1% | -19.8M▲ 0% |
FCF Margin % | -750.44% | -556.27% | -180.79% | -142.61% | -51.69% | -58.29% | -42.02% | -0.92% | -8.88% | -7.69% |
FCF Growth % | -553.36% | -70.96% | -110.26% | 14.86% | 66.94% | -107.71% | 26.23% | 97.66% | -1027.05% | 25.97% |
FCF per Share | -1.66 | -2.18 | -4.13 | -2.87 | -0.64 | -1.00 | -0.77 | -0.02 | -0.13 | -0.15 |
FCF Conversion (FCF/Net Income) | 0.56x | -0.62x | 3.68x | 0.33x | 0.22x | 2.54x | 0.16x | -0.09x | 0.24x | 0.79x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OGI Key Ratios
Organigram Global Inc. (OGI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -17.11% | 15.33% | -3.73% | -43.46% | -33.54% | -2.89% | -58.86% | -15.73% | -5.43% | -6.76% |
Return on Invested Capital (ROIC) | -13.16% | 17.44% | 1.48% | -30.84% | -17.03% | -7.41% | -53.2% | -12.02% | -17.83% | -6.3% |
Gross Margin | -61.18% | -215.42% | 60.28% | -65.08% | -35.87% | 21.65% | 23.51% | 29.73% | 3.67% | 29.08% |
Net Margin | -202.08% | 165.04% | -11.87% | -156.87% | -165.11% | -9.8% | -153.8% | -28.43% | -9.55% | -9.7% |
Debt / Equity | 0.04x | 0.54x | 0.15x | 0.35x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.02x |
Interest Coverage | -39.96x | 3.75x | 0.39x | -23.41x | -43.16x | -32.50x | -175.60x | - | - | - |
FCF Conversion | 0.56x | -0.62x | 3.68x | 0.33x | 0.22x | 2.54x | 0.16x | -0.09x | 0.24x | 0.79x |
Revenue Growth | -12.06% | 130.64% | 546.98% | 7.94% | -8.79% | 84.19% | 2.33% | 7.13% | 16.42% | 32.58% |
Related:OGI Dividend History·OGI Revenue History·OGI Price History·OGI P/E History·OGI Financial Ratios·OGI Institutional Holders
OGI Frequently Asked Questions
Organigram Global Inc. (OGI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Organigram Global Inc. (OGI) reported $257.3M in revenue for fiscal year 2025.
Organigram Global Inc. (OGI) grew revenue by 16.4% over the past year. This is strong growth.
Organigram Global Inc. (OGI) reported a net loss of $25.0M for fiscal year 2025.
Dividend & Returns
Organigram Global Inc. (OGI) has a return on equity (ROE) of -5.4%. Negative ROE indicates the company is unprofitable.
Organigram Global Inc. (OGI) had negative free cash flow of $19.8M in fiscal year 2025, likely due to heavy capital investments.